Opinion

Quality shouldn’t be an afterthought but an integral part of manufacturing process: Dr Rajeev Raghuvanshi, DCGI

How does the revised implementation of Schedule M align India’s pharmaceutical sector with global GMP st...

10 February, 2025 | Monday | Views

Medtech

NeuraSim & QWR revolutionise Amblyopia with India’s first AI-powered immersive VR therapy

Bengaluru-based heath-tech startup NeuraSim Health, in collaboration with QWR - Fabless OEM XR Hardware manufa...

13 February, 2025 | Thursday | News

Start-Ups

image credit- shutterstock
Nivaan Care raises $4.25 M in seed funding from Endiya Partners and W Health Ventures

Delhi-based startup Nivaan Care, India’s first multidisciplinary chronic pain management clini...

13 February, 2025 | Thursday | News

Supplier

Utthunga and VindAir collaborate to advance smart solutions for pharma and healthcare industries

Utthunga, a leading provider of industrial automation and smart manufacturing solutions and services, has ente...

12 February, 2025 | Wednesday | News

Inside Magazine

How India is Pulling In European Life Sciences Sector

How India is Pulling In European Life Sciences Sector
When the world was struggling with COVID-19 in 2020 and 2021, the partnership between Indian and European organizations proved to be a historic accomplishment in the field of global life sciences. It was able to deliver more than two billion doses of the COVID-19 vaccine, which was developed by the University of Oxford and AstraZeneca, both from the United Kingdom, and manufactured by Serum Institute of India (SII) in India, to more than 170 countries starting in November 2020, marking a significant milestone in the global pandemic response. India's economical production in the biopharma industry allowed it to reach this significant milestone. India's advantages, including cost-effective manufacturing, a skilled workforce, and a growing but robust research ecosystem, are making it an attractive destination for outsourcing and joint ventures. These collaborations have led to the development of innovative healthcare solutions and have expanded market access for both Indian and European firms. The India-Europe collaboration in life sciences has evolved into a dynamic partnership fostering innovation, investment, and shared expertise. While significant strides have been made in contract research, vaccine production, and biosimilars, there remains potential for greater collaboration in new drug discovery sciences. As European companies expand their R&D and manufacturing presence in India, the mutual focus on academic research and healthcare resilience positions this partnership as a global leader in life sciences innovation. 

For Feedback, please email us at: communications@mmactiv.com

Sign up here to access BioSpectrum India Flip Book.

Sign up here to access BioSpectrum India Flip Book

Videos

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy